Pharmacokinetics of extended-release dipyridamole following administration through a gastrostomy tube: An open-label, case-control, two-centre study

Clinical Drug Investigation

Volumn 30, Issue 7, 2010, Pages 483-488

  Batista, Leonardo M ^a   Crandell, David ^b   Lima, Fabricio O ^a   Greer, David M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

Author keywords

Aspirin; Dipyridamole; Dysphagia; Pharmacokinetics; Stroke; Therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RELEASE; DYSPHAGIA; EXTENDED DRUG RELEASE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SECONDARY PREVENTION; STOMACH TUBE;

AGED; AGGRECANS; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; DEGLUTITION DISORDERS; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; FEMALE; GASTROSTOMY; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 77953328467     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11536220-000000000-00000     Document Type: Article

References (10)

1. Barritt AW, Smithard DG. Role of cerebral cortex plasticity in the recovery of swallowing function following dysphagic stroke. Dysphagia 2009 Mar; 24 (1): 83-90
2. Falsetti P, Acciai C, Palilla R, et al. Oropharyngeal dysphagia after stroke: incidence, diagnosis, and clinical predictors in patients admitted to a neurorehabilitation unit. J Stroke CerebrovascDis 2009 Sep-Oct; 18 (5): 329-335
3. Schmid J, Beschke K, Roth W, et al. Rapid, sensitive determination of dipyridamole in human plasma by highperformance liquid chromatography. J Chromatogr 1979 Jun; 163 (2): 239-243
4. Aggrenox- (aspirin/extended-release dipyridamole) 25mg/ 200mg capsules prescribing information. Boehringer Ingelheim International GmbH [online]. Available from URL: http://bidocs.boehringer-ingelheim.com/BIWebAc cess/ViewServlet.ser?docBase=renetnt&folderPath=/Pre scribing+Information/ PIs/Aggrenox+Caps/Aggrenox.pdf [Accessed 2009 Oct 19]
5. Serebruany V, Pokov I, Hanley D. Spectrofluorimetric assessment of plasma dipyridamole stability: sample storage for multicenter clinical trials? Thromb Res 2008; 123 (1): 184-186
6. Martino R, Foley N, Bhogal S, et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005 Dec; 36 (12): 2756-2763
7. Daniels SK, Foundas AL. Lesion localization in acute stroke patients with risk of aspiration. J Neuroimaging 1999 Apr; 9 (2): 91-98
8. Dalvi SS, Gupta KC, Pohujani SM, et al. Bioavailability of aspirin after oral and rectal administration in volunteers and patients with fever. J Postgrad Med 1985 Oct; 31 (4): 192-195
9. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and TIA. Stroke 2008 May; 39: 1647-1652
10. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996 Nov; 143 (1-2): 1-13